𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Phase II study of mitomycin C and cisplatin in heavily pretreated advanced breast cancer

✍ Scribed by Xichun Hu; Haiyi Guo; Xinmin Zhao; Zhonghua Wang; Xinmiao Yang; Xiangjin Liu; Jin Li

Publisher
Springer
Year
2006
Tongue
English
Weight
214 KB
Volume
5
Category
Article
ISSN
1610-1979

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

A phase II study of combined 5-fluoroura
A phase II study of combined 5-fluorouracil and mitomycin C in advanced breast cancer
✍ Willy Mattsson; Finn Von Eyben; Lennart Hallsten; GΓΆran Bjelkengren πŸ“‚ Article πŸ“… 1982 πŸ› John Wiley and Sons 🌐 English βš– 340 KB πŸ‘ 2 views

In a Phase I1 study, 50 patients with advanced breast cancer were treated with a combination of 5fluorouracil(lOO0 mg/m2 on days 1 and 2) and mitomycin C (6 mg/m2 on day 2) (FuMi regimen). The courses were repeated every third to sixth week. Although 35 patients had previously received combination c

Phase II study of vincristine, mitomycin
Phase II study of vincristine, mitomycin-C and mitoxantrone in advanced breast cancer: a preliminary report of response and toxicity
✍ Timothy J. Perren; George Blackledge; John J. Mould; Anula Dharmapriya Chetiyawa πŸ“‚ Article πŸ“… 1985 πŸ› Springer US 🌐 English βš– 310 KB

Nineteen patients with advanced, previously treated breast cancer received treatment with vincristine 2 mg i.v., mitomycin-C 6 mg/m2 and mitoxantrone (Novantrone; dihydroxyanthracenedione) 12 mg/m2 i.v. every three weeks. Thirteen patients are evaluable for response and toxicity. Partial remission w